HCmed Innovations is redefining how medicines reach patients around the world
HCmed Innovations is redefining how medicines reach patients around the world. As a publicly listed med-tech company on the Taiwan Stock Exchange, HCmed collaborates with pharmaceutical and biotech leaders to deliver inhalation therapies enabled by mesh nebulization.